BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21844742)

  • 41. Social and individual risk determinants of HIV testing practices among noninjection drug users at high risk for HIV/AIDS.
    White K; Rudolph AE; Jones KC; Latkin C; Benjamin EO; Crawford ND; Fuller CM
    AIDS Care; 2013; 25(2):230-8. PubMed ID: 22834456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV infection among patients in U.S. acute care hospitals. Strategies for the counseling and testing of the hospital patients. The Hospital HIV Surveillance Group.
    Janssen RS; St Louis ME; Satten GA; Critchley SE; Petersen LR; Stafford RS; Ward JW; Hanson DL; Olivo N; Schable CA
    N Engl J Med; 1992 Aug; 327(7):445-52. PubMed ID: 1625734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characteristics of U.S. emergency departments that offer routine human immunodeficiency virus screening.
    Berg LJ; Delgado MK; Ginde AA; Montoy JC; Bendavid E; Camargo CA
    Acad Emerg Med; 2012 Aug; 19(8):894-900. PubMed ID: 22849642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current HIV epidemiology and revised recommendations for HIV testing in health-care settings.
    Branson B
    J Med Virol; 2007; 79 Suppl 1():S6-10. PubMed ID: 17874432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Late versus early testing of HIV--16 Sites, United States, 2000-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Jun; 52(25):581-6. PubMed ID: 12836626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends in HIV Testing Among U.S. Older Adults Prior to and Since Release of CDC's Routine HIV Testing Recommendations: National Findings from the BRFSS.
    Ford CL; Mulatu MS; Godette DC; Gaines TL
    Public Health Rep; 2015; 130(5):514-25. PubMed ID: 26327729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Associations Between Clinic-Based HIV Testing Guidelines and Population-Level HIV Testing Rates in the United States.
    Siddiqi KA; Gwynn M; Olatosi B; Ostermann J
    J Assoc Nurses AIDS Care; 2023 Jul-Aug 01; 34(4):349-362. PubMed ID: 37141167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness of HIV testing and treatment in the United States.
    Walensky RP; Freedberg KA; Weinstein MC; Paltiel AD
    Clin Infect Dis; 2007 Dec; 45 Suppl 4(Suppl 4):S248-54. PubMed ID: 18190295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changing epidemiology of HIV/AIDS in the United States: implications for enhancing and promoting HIV testing strategies.
    Fenton KA
    Clin Infect Dis; 2007 Dec; 45 Suppl 4():S213-20. PubMed ID: 18190289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Barriers to HIV testing in Côte d'Ivoire: the role of individual characteristics and testing modalities.
    Jean K; Anglaret X; Moh R; Lert F; Dray-Spira R
    PLoS One; 2012; 7(7):e41353. PubMed ID: 22815995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Centers for Disease Control and Prevention Funding for HIV Testing Associated With Higher State Percentage of Persons Tested.
    Hayek S; Dietz PM; Van Handel M; Zhang J; Shrestha RK; Huang YL; Wan C; Mermin J
    J Public Health Manag Pract; 2015; 21(6):531-7. PubMed ID: 25679771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CDC recommendations for opt-out testing and reactions to unanticipated HIV diagnoses.
    Galletly CL; Pinkerton SD; Petroll AE
    AIDS Patient Care STDS; 2008 Mar; 22(3):189-93. PubMed ID: 18290754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acceptability of routine HIV testing ("opt-out") in antenatal services in two rural districts of Zimbabwe.
    Perez F; Zvandaziva C; Engelsmann B; Dabis F
    J Acquir Immune Defic Syndr; 2006 Apr; 41(4):514-20. PubMed ID: 16652062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrating Routine HIV Testing into Family Planning Clinics That Treat Adolescents and Young Adults.
    Buzi RS; Madanay FL; Smith PB
    Public Health Rep; 2016; 131 Suppl 1(Suppl 1):130-8. PubMed ID: 26862238
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors associated with HIV testing among sexually active adolescents: a Massachusetts survey.
    Samet JH; Winter MR; Grant L; Hingson R
    Pediatrics; 1997 Sep; 100(3 Pt 1):371-7. PubMed ID: 9282708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimated HIV Inter-test Interval Among People at High Risk for HIV Infection in the U.S.
    An Q; Song R; Finlayson TJ; Wejnert C; Paz-Bailey G;
    Am J Prev Med; 2017 Sep; 53(3):355-362. PubMed ID: 28336355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Computer-Based Substance Use Reporting and Acceptance of HIV Testing Among Emergency Department Patients.
    Aronson ID; Cleland CM; Rajan S; Marsch LA; Bania TC
    AIDS Behav; 2020 Feb; 24(2):475-483. PubMed ID: 31049808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIV seropositivity rates in outreach-based counseling and testing services: program evaluation.
    DiFranceisco W; Holtgrave DR; Hoxie N; Reiser WJ; Resenhoeft R; Pinkerton SD; Vergeront J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):282-8. PubMed ID: 9803971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does the Centers for Disease Control and Prevention's Recommendation of Opt-Out HIV Screening Impact the Effect of Stigma on HIV Test Acceptance?
    Mahajan AP; Kinsler JJ; Cunningham WE; James S; Makam L; Manchanda R; Shapiro MF; Sayles JN
    AIDS Behav; 2016 Jan; 20(1):107-114. PubMed ID: 26462670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Testing for human immunodeficiency virus among cancer survivors under age 65 in the United States.
    Li J; Thompson TD; Tai E; Zhao G; Oster AM
    Prev Chronic Dis; 2014 Nov; 11():E200. PubMed ID: 25393748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.